Literature DB >> 23425821

Human recombinant lactoferrin for sepsis: too good to be true?.

Russell McCulloh, Steven M Opal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23425821     DOI： 10.1097/CCM.0b013e3182770fd6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  4 in total

1.  The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*.

Authors:  Steven M Opal; R Phillip Dellinger; Jean-Louis Vincent; Henry Masur; Derek C Angus
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

2.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

3.  Innate immunity gene expression changes in critically ill patients with sepsis and disease-related malnutrition.

Authors:  Robert Słotwiński; Agnieszka Sarnecka; Aleksandra Dąbrowska; Katarzyna Kosałka; Ewelina Wachowska; Barbara J Bałan; Marta Jankowska; Teresa Korta; Grzegorz Niewiński; Andrzej Kański; Małgorzata Mikaszewska-Sokolewicz; Mohammad Omidi; Krystyna Majewska; Sylwia M Słotwińska
Journal:  Cent Eur J Immunol       Date:  2015-10-15       Impact factor: 2.085

4.  Biomarkers of sepsis.

Authors:  Sung-Yeon Cho; Jung-Hyun Choi
Journal:  Infect Chemother       Date:  2014-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.